ETF Battles: ARKG vs. VHT – Which Healthcare ETF is the Better Opportunity?

Are you ready to rumble? Season II of ETF Battles is in full swing and in this episode you’ll watch the ARK Genomic Revolution Multi-Sector ETF (ARKG) vs. the Vanguard Healthcare Index ETF (VHT). As the healthcare sector innovates with CRISPR, Covid-19 vaccines, DNA sequencing, stem cell research, and other therapies, which healthcare ETF is better positioned for future growth?

Keep in mind the Vanguard ETF (VHT) is indexed while the ARK ETF (ARKG) is actively managed. And while they both invest in the same industry sector, they do it very differently.

Ron DeLegge @ETFguide referees this audience requested matchup with guest judges Todd Rosenbluth at CFRA Research and Dave Nadig at ETF Trends providing their research insights.

Each ETF is judged against the other in key categories like cost, exposure strategy, performance and a mystery category. Find out who wins the battle.

*****GET YOUR BATTLE RECAP SUMMARY*****
Download the ETF Battle Recap Summary of this matchup
http://www.tinyurl.com/1ktzib9s
******************************************************

#ARKETF #Vanguard #ETF

Get in touch with our judges:
CFRA Research
https://www.cfraresearch.com/​

ETF Trends
http://www.etftrends.com

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

Your Resources From ETFguide

Get Feedback on Your Portfolio's Risk

Check Your Investment Performance

Get Help With Your Investing Habits

60 Smart Ways to Retire Better